1-3 of 3
Markus Pfirrmann, MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Dose Therapy with Autologous Stem Cell Transplantation Vs Standard Dose Chemotherapy In Multiple Myeloma: A Meta-Analysis

Florian Faußner, Markus Pfirrmann, MSc, PhD, Wolfram Dempke, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3559.
https://doi.org/10.1182/blood.V116.21.3559.3559
Published: 2010
Journal Articles

Randomized Comparison of Primary Allogeneic Stem Cell Transplantation and Best Available Drug Treatment in Chronic Myeloid Leukemia.

Rudiger Hehlmann, MD, Markus Pfirrmann, MSc, Andreas Hochhaus, MD, Martin C. Müller, MD, Jörg Hasford, MD, Hans-Jochem Kolb, MD, Hermann Heimpel, MD, Dieter K. Hossfeld, MD, Alois Gratwohl, MD, the German CML-Study Group
Journal: Blood
Blood (2006) 108 (11): 427.
https://doi.org/10.1182/blood.V108.11.427.427
Published: 2006
Journal Articles

Heterogeneous Prognostic Impact of 9q+ Deletions in Patients with Chronic Myelogenous Leukemia.

Sebastian Kreil, MD, Katherine Waghorn, Markus Pfirrmann, MSc, Andreas Reiter, MD, Rudiger Hehlmann, MD, Andreas Hochhaus, MD, Nicholas C.P. Cross, PhD
Journal: Blood
Blood (2006) 108 (11): 2111.
https://doi.org/10.1182/blood.V108.11.2111.2111
Published: 2006